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Adverse Health Effects 
from Combustion-Derived 
Nanoparticles: The Relative 
Role of Intrinsic Particle 
Toxicity and Host Response
doi:10.1289/ehp.0800218
It is widely accepted that airborne pollu-
tion causes adverse health effects in humans 
(Gauderman et al. 2007). In addition to the 
concentration of particulate matter (PM), 
these effects have been related to innate par-
ticle toxicity. Stoeger et al. (2009) recently 
showed that, with a slope that significantly 
depends on particle structure, surface, and 
organic carbon content, combustion-derived 
nanoparticles behave in a different manner in 
in vitro systems and when reacting with lung 
surface (i.e. after particle–lung interaction).
We have stressed that mechanistic link-
ages between PM and health effects should be 
investigated in more detail (Cetta et al. 2007, 
2008). Here, we would like to comment 
on the role of the individual response in the 
occurrence of the clinically evident outcome, 
that is, how individual charac  teris  tics of the 
host, in the presence of the same (or similar) 
noxious agents, are responsible for or deter-
mine the type and the severity of the response.
Until now, toxicity has been considered 
mainly as an intrinsic property of each pollut-
ant, depending on size, type, and composition 
of each particle. Stoeger et al. (2009) focused 
specifically on structure, BET (Brunauer, 
Emmett, and Teller) surface area, and oxida-
tive potency. Interestingly, they stressed par-
ticle–lung interaction and the ability of some 
particles rich in organic content, namely, soot 
with high organic content, to determine a 
higher than expected inflammatory response 
due to increased cytochrome P450 1A1 
induction; they also introduced a new param-
eter, inflammatory efficacy, in addition to 
oxidative potency.
In our opinion, this could be just the top 
of the iceberg. In fact, “oxidative stress” is a 
working hypothesis in the search for a com-
mon mechanistic linkage between particulate 
material and adverse health effects. But it is 
not unique. In particular, in a recent in vitro 
study in which different types of particles were 
used (PM < 2.5 or ≤ 10 µm in aero  dynamic 
diameter, tire debris), the same concentration 
of different particles with the same exposure 
time elicited different effects on sperm cell 
function (motility, viability, rate of apop-
tosis) (Collodel G, Geminiani M, Cetta F, 
Camatini M, Bolzacchini E, Renieri T, 
unpublished data). However, variability of the 
observed effects was less than that elicited by 
changing the host, with lower adverse effects 
in New Zealand rabbit sperm, more evident 
effects in human sperm, and very severe effects 
in humans with previous impaired sperm 
function (e.g., varicocele). Sperm cell func-
tion is easy to quantify and compare not only 
among different pollutants but also among 
different host species or subgroups. These 
findings are in accordance with recent epi-
demiologic data showing more pronounced 
respiratory and cardiovascular effects in 
patients with previous respiratory and cardio-
vascular impairment or specific susceptibility, 
respectively (Gauderman et al. 2007).
The results of these studies will also have 
relevant implications for policy makers (Cetta 
et al. 2007). In fact, until now, contrast meas-
ures have mainly been directed to reduce PM 
concentration. Curent evidence suggests that—
more important than reducing the overall PM 
concentration—it is of paramount importance 
to reduce selectively the concentration of those 
pollutants that are more toxic or more strictly 
related with adverse health effects, such as 
traffic-related particles. In the future, because 
of the better knowledge of the host response 
and of the variability of individual susceptibil-
ity in the occurrence of these effects, a major 
goal for policy makers will be the proper and 
early recognition—by means of sensible and   
specific tests—of at-risk subpopulations.
This early recognition of at-risk sub  popu-
la  tions could facilitate better prevention or 
reduction of negative effects of host–pollutant 
interactions.
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Prenatal Lead Exposure 
and Schizophrenia: Further 
Evidence and More 
Neurobiological Connections
doi:10.1289/ehp.0800484
In 2004, Opler et al. published a study in 
Environmental Health Perspectives (EHP) sug-
gesting an association between pre  natal lead 
(Pb2+) exposure and schizophrenia (Opler 
et al. 2004). In the November 2008 issue of 
EHP, Opler et al. (2008) further supported 
this association using a different cohort of 
subjects. In a letter published in EHP in 2004 
(Guilarte 2004), I indicated that a plausible 
neurobiological connection between prenatal 
Pb2+ exposure and schizophrenia may be that 
Pb2+ is a potent antagonist of the N-methyl-
d-aspartate (NMDA) receptor (NMDAR), 
and NMDAR hypofunction is thought to be 
involved in the pathophysiology of the disease. 
Since then, another plausible neurobiologi-
cal connection has surfaced, and this relates 
to hippo  campal neuro  genesis. Neurogenesis 
occurs not only during development but is 
also prominent in the adult brain (Laplagne 
et al. 2006). A well-characterized neurogenic 
zone in the adult brain is the subgranular 
zone of the dentate gyrus (DG) in the hippo-
campus (Zhao et al. 2008). Although the sig-
nificance of newly born neurons in the adult 
hippo  campus is currently under investigation, 
the overwhelming evidence supports a role in 
hippocampus-dependent learning (Dupret 
et al. 2008; Imayoshi et al. 2008). 
Schizophrenia patients express cognitive 
deficits that may be related to hippo  campal 
dysfunction (Gothelf et al. 2000; Sweatt 2004). 
So, what is the new neurobiological connec-
tion between Pb2+ exposure and schizophrenia? 
Recent evidence indicates that neurogenesis is 
decreased in schizophrenia patients, and this 
decrease may contribute to their cognitive dys-
function (Kempermann et al. 2008; Reif et al. 
2006). In an animal model using the NMDAR 
antagonist phencyclidine (PCP) to induce 
schizophrenia-like symptoms in mice, Maeda 
et al. (2007) observed reduced DG neuro-
genesis that was reversed by the atypical anti-
psychotic drug clozapine. Co-administration 
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of d-serine and glycine also inhibited the PCP-
induced decrease in neurogenesis. PCP, like 
Pb2+, is an NMDAR antagonist, and D-serine 
and glycine activate NMDAR; this suggests 
that chronic NMDAR hypo  function decreases 
neuro  genesis in the hippo  campus, an observa-
tion consistent with my comments in 2004 
(Guilarte 2004). Models of developmental 
Pb2+ exposure have also shown decreased DG 
neurogenesis and are associated with deficits in 
learning (Jaako-Movits et al. 2005; Verina et al. 
2007). Therefore, reduced DG neuro  genesis 
appears to be a common factor in schizophre-
nia and in animal models of schizophrenia and 
developmental Pb2+ exposure. 
Schizophrenia is a neurodevelopmental dis-
order that is expressed later in life. Pb2+ is a 
neurotoxicant that is known to cause develop-
mental abnormalities. Animal models of devel-
opmental Pb2+ exposure express a behavioral 
phenotype with features that overlap with those 
in animal models of schizo  phrenia, including 
increased spontaneous activity, decreased social 
interaction, and learning deficits (Moreira et al. 
2001; Nihei et al. 2000). Also, some of the 
behavioral effects described in adolescents with 
early-life Pb2+ exposure are simi  lar to those 
expressed in schizo  phrenia patients (Opler and 
Susser 2005). Thus, although the environmen-
tal causes of schizophrenia have not evaluated 
environmental toxicants, the emerging evi-
dence from the human studies by Opler and 
colleagues and animal studies suggest that pre-
natal Pb2+ exposure may be an environmental 
risk factor for schizophrenia. 
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Plant Food Allergens: Another 
Climate Change–Public Health 
Link
doi:10.1289/ehp.0900670
The recent article titled “Rising CO2, Climate 
Change, and Public Health: Exploring the 
Links to Plant Biology” (Ziska et al. 2009) 
is an interesting and useful commentary on 
this important topic. Although some aspects 
of the article have been considered in some 
detail previously, such as the impacts of climate 
change and elevated carbon dioxide on aero-
biology (e.g., Beggs 2004; Confalonieri et al. 
2007) and the human health implications of 
this (e.g., Beggs and Bambrick 2005; Shea et al. 
2008), the broader review of links between cli-
mate change, plant biology, and human health, 
particularly the examination of toxicology and 
pharmacology, is timely and brings together a 
number of somewhat distinct areas of research. 
In their article, Ziska et al. (2009) men-
tioned the potential impacts of elevated atmo-
spheric CO2 concentration on ragweed pollen 
allergenicity and poison ivy toxicity, and there-
fore considered respiratory allergies and contact 
dermatitis, respectively. Surprisingly, however, 
these authors did not recognize that there is 
a third major mecha  nism for human contact 
with plant allergens: ingestion. In an article 
published in Air Quality, Atmosphere & Health, 
I (Beggs and Walczyk 2008) proposed, for the 
first time, a link between climate change and 
plant food allergens, such as peanut, and the 
rise of associated diseases. There is potential for 
such impacts in the future, but they may have 
already occurred (Beggs and Walczyk 2008).
I agree that the plant biology aspect of cli-
mate change and human health is underappreci-
ated, and I also strongly support Ziska et al.’s 
(2009) highlighting of the many key questions 
that remain to be addressed and the urgent 
need to find answers to these questions. Studies 
should also investigate the impacts of climate 
change, particularly elevated CO2, on plant food 
allergens, especially their relative concentrations.
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ClarifiCation
On p. A155 of the April Focus article 
[Environ Health Perspect 117:A150–A156 
(2009)], a statement reads, “The primary 
global impact of oil sands comes through 
the release of greenhouse gases created when 
about 800 million cubic feet of natural gas 
(approximately 10% of Canada’s total natu-
ral gas consumption) is burned daily to cre-
ate heat for extraction and upgrading, says 
Stringham.” To clarify: This statement refers 
to the global impact of oil sands production. 
As noted in the preceding paragraph of the 
article, most of the greenhouse gas emissions 
related to oil sands overall come from burn-
ing the fuel derived from these reserves.